These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 34503994)

  • 1. 5-Aza-4'-thio-2'-deoxycytidine, a New Orally Bioavailable Nontoxic "Best-in-Class": DNA Methyltransferase 1-Depleting Agent in Clinical Development.
    Parker WB; Thottassery JV
    J Pharmacol Exp Ther; 2021 Nov; 379(3):211-222. PubMed ID: 34503994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel DNA methyltransferase-1 (DNMT1) depleting anticancer nucleosides, 4'-thio-2'-deoxycytidine and 5-aza-4'-thio-2'-deoxycytidine.
    Thottassery JV; Sambandam V; Allan PW; Maddry JA; Maxuitenko YY; Tiwari K; Hollingshead M; Parker WB
    Cancer Chemother Pharmacol; 2014 Aug; 74(2):291-302. PubMed ID: 24908436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The development of β-selective glycosylation reactions with benzyl substituted 2-deoxy-1,4-dithio-D-
    Wishka DG; Lopez OD; Rudchenko VF; Huang G; Bahde R; Kumar V; Denysenko SM; Zhang L; Zhang M; Teicher BA; Morris J
    Nucleosides Nucleotides Nucleic Acids; 2021; 40(1):68-95. PubMed ID: 33063584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA damage, demethylation and anticancer activity of DNA methyltransferase (DNMT) inhibitors.
    Laranjeira ABA; Hollingshead MG; Nguyen D; Kinders RJ; Doroshow JH; Yang SX
    Sci Rep; 2023 Apr; 13(1):5964. PubMed ID: 37045940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consequences of combining siRNA-mediated DNA methyltransferase 1 depletion with 5-aza-2'-deoxycytidine in human leukemic KG1 cells.
    Vispé S; Deroide A; Davoine E; Desjobert C; Lestienne F; Fournier L; Novosad N; Bréand S; Besse J; Busato F; Tost J; De Vries L; Cussac D; Riond J; Arimondo PB
    Oncotarget; 2015 Jun; 6(17):15265-82. PubMed ID: 25948775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Aza-deoxycytidine induces selective degradation of DNA methyltransferase 1 by a proteasomal pathway that requires the KEN box, bromo-adjacent homology domain, and nuclear localization signal.
    Ghoshal K; Datta J; Majumder S; Bai S; Kutay H; Motiwala T; Jacob ST
    Mol Cell Biol; 2005 Jun; 25(11):4727-41. PubMed ID: 15899874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-aza-2'-deoxycytidine induces alterations in murine spermatogenesis and pregnancy outcome.
    Kelly TL; Li E; Trasler JM
    J Androl; 2003; 24(6):822-30. PubMed ID: 14581508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Aza-dC promotes T-cell acute lymphoblastic leukemia cell invasion via downregulation of DNMT1 and upregulation of MMP-2 and MMP-9.
    Lin C; Xie Y; Huang W; Lin D; Lin L
    Exp Hematol; 2022 Oct; 114():43-53.e2. PubMed ID: 35908628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of DNA methylation in L1210 leukemic cells by 5-aza-2'-deoxycytidine as a possible mechanism of chemotherapeutic action.
    Wilson VL; Jones PA; Momparler RL
    Cancer Res; 1983 Aug; 43(8):3493-6. PubMed ID: 6190553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting of 5-aza-2'-deoxycytidine residues by chromatin-associated DNMT1 induces proteasomal degradation of the free enzyme.
    Patel K; Dickson J; Din S; Macleod K; Jodrell D; Ramsahoye B
    Nucleic Acids Res; 2010 Jul; 38(13):4313-24. PubMed ID: 20348135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of 5-aza-2'-deoxycytidine on survival and cell cycle progression of L1210 leukemia cells.
    Chabot GG; Momparler RL
    Leuk Res; 1986; 10(5):533-7. PubMed ID: 2423812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of deoxycytidine on the metabolism and cytotoxicity of 5-aza-2'-deoxycytidine and arabinosyl 5-azacytosine in normal and leukemic human myeloid progenitor cells.
    Bhalla K; Cole J; MacLaughlin W; Arlin Z; Baker M; Graham G; Grant S
    Leukemia; 1987 Dec; 1(12):814-9. PubMed ID: 2447450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-aza-2'-deoxycytidine therapy in patients with acute leukemia inhibits DNA methylation.
    Momparler RL; Bouchard J; Onetto N; Rivard GE
    Leuk Res; 1984; 8(2):181-5. PubMed ID: 6201685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. F-aza-T-dCyd (NSC801845), a Novel Cytidine Analog, in Comparative Cell Culture and Xenograft Studies with the Clinical Candidates T-dCyd, F-T-dCyd, and Aza-T-dCyd.
    Morris J; Wishka DG; Lopez OD; Rudchenko V; Huang G; Hoffman SN; Borgel S; Georgius K; Carter J; Stotler H; Kunkel MW; Collins JM; Hollingshead MG; Teicher BA
    Mol Cancer Ther; 2021 Apr; 20(4):625-631. PubMed ID: 33811149
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Gilmartin AG; Groy A; Gore ER; Atkins C; Long ER; Montoute MN; Wu Z; Halsey W; McNulty DE; Ennulat D; Rueda L; Pappalardi M; Kruger RG; McCabe MT; Raoof A; Butlin R; Stowell A; Cockerill M; Waddell I; Ogilvie D; Luengo J; Jordan A; Benowitz AB
    Haematologica; 2021 Jul; 106(7):1979-1987. PubMed ID: 32586904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy of L1210 and L1210/ARA-C leukemia with 5-aza-2'-deoxycytidine and 3-deazauridine.
    Momparler RL; Momparler LF
    Cancer Chemother Pharmacol; 1989; 25(1):51-4. PubMed ID: 2480188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in DNA damage produced by incorporation of 5-aza-2'-deoxycytidine or 5,6-dihydro-5-azacytidine into DNA of mammalian cells.
    Covey JM; D'Incalci M; Tilchen EJ; Zaharko DS; Kohn KW
    Cancer Res; 1986 Nov; 46(11):5511-7. PubMed ID: 2428479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-Aza-2'-deoxycytidine, a DNA methylation inhibitor, induces cytotoxicity, cell cycle dynamics and alters expression of DNA methyltransferase 1 and 3A in mouse hippocampus-derived neuronal HT22 cells.
    Yang J; Tian X; Yang J; Cui J; Jiang S; Shi R; Liu Y; Liu X; Xu W; Xie W; Jia X; Bade R; Zhang T; Zhang M; Gong K; Yan S; Yang Z; Shao G
    J Toxicol Environ Health A; 2017; 80(22):1222-1229. PubMed ID: 28880816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of DNMT1 inhibitors by methylome profiling identifies unique signature of 5-aza-2'deoxycytidine.
    Mackin SJ; O'Neill KM; Walsh CP
    Epigenomics; 2018 Aug; 10(8):1085-1101. PubMed ID: 30070602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-aza-2'-deoxycytidine-induced genome rearrangements are mediated by DNMT1.
    Maslov AY; Lee M; Gundry M; Gravina S; Strogonova N; Tazearslan C; Bendebury A; Suh Y; Vijg J
    Oncogene; 2012 Dec; 31(50):5172-9. PubMed ID: 22349820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.